How did Finland develop from one of the poorest countries in Europe to one of the most successful nations in the world? Join us as we explore Finland’s journey through the lens of Finnish-American relations. How has the United States impacted Finland, and what kind of impressions has “brave little Finland” made on Americans? We will examine these important questions over the course of the next twelve posts, one per decade, to get a better understanding of our common...

Read more

CINCINNATI—Todd Schwartz, a 28-year U.S. and international diplomat, is the new executive director of the European American Chamber of Commerce (EACC)—Greater Cincinnati. He begins today in his new role. “It’s my goal to promote the Queen City as a destination for European investment,” Schwartz said. “More than 200 firms in Europe know this region as America’s heartland, leveraging world-class education and cultural institutions. I will work to position the EACC as the leading source of expertise and innovation for business...

Read more

Voila Chocolat is  proud to say that, in December, we were chosen and featured by WABC Channel 7 as one of seven do-not-miss holiday destinations in NYC: Watch the Video here: https://abc7ny.com/society/a-new-york-holiday---part-3/1660296/ Compliments of Voila Chocolat - a member of the EACCNY

Read more

Beginning on January 17, 2017, the U.S. Department of Homeland Security (DHS) will implement a new rule that amends certain regulations relating to employment-based immigrant and nonimmigrant visa programs.  The rule's goal is to ease U.S. employers’ ability to hire and retain high-skilled personnel who have been granted employment-based immigrant visas and are waiting to become lawful permanent residents. The rule effectively improves the job mobility process for those workers by allowing them to accept promotions, change employers, change positions...

Read more

On January 13, 2017, the U.S. Food and Drug Administration (FDA) issued a discussion paper1 in which the FDA announced that it would delay issuing final guidance on laboratory developed tests (LDTs).2 The FDA cited two reasons for the delay: i) to allow further public discussion on an appropriate oversight approach; and ii) to give Congress, via its oversight committees, the opportunity to develop a legislative solution to LDT oversight. In lieu of issuing final guidance, the FDA synthesized a...

Read more

The Blue Star Strategies team would like to thank you for all your support this past year. We remain dedicated to our mission of providing our clients and partners with focused attention, results oriented strategies, and practical solutions. We begin this new year in the Janus* tradition of reflecting back and looking ahead by recognizing that our work is a continuous journey. In this way, we look forward to building on recent achievements and to working towards marking new and exciting milestones with you...

Read more